Introducing BIONi010-C-42: a doxycycline-inducible CRE recombinase iPSC line with targeted integration into the AAVS1 safe harbour locus.

Designed for precise temporal control of gene editing and recombination, this iPSC line features:
– Stable AAVS1 integration
– Tight doxycycline-inducible CRE expression
– Scalable for developmental biology and translational research applications

A powerful tool for researchers advancing next-generation stem cell and functional genomics studies.

See full characterisation here: https://ebisc.org/BIONi010-C-42